Glaucoma trials in Japan

1 trial · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)

  Where

  Multiple Locations

  People

  480

  Run by

  Bayer

  See details and how to joinNCT04519619